Cite
HARVARD Citation
Liu, Y. et al. (2021). Cyclin-dependent kinase inhibitor roscovitine attenuates liver inflammation and fibrosis by influencing initiating steps of liver injury. Clinical science. 135 (7), pp. 925-941. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liu, Y. et al. (2021). Cyclin-dependent kinase inhibitor roscovitine attenuates liver inflammation and fibrosis by influencing initiating steps of liver injury. Clinical science. 135 (7), pp. 925-941. [Online].